Skip to main content
Figure 3 | Cardiovascular Ultrasound

Figure 3

From: Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease

Figure 3

FMD during study protocol. Values are presented as median (Q1-Q3). Iva: ivabradine; FMD: flow-mediated dilation; baseline: difference between FMD at 08.00 and 12.00 at study visit 1 (without Iva); Iva acute effect: difference between FMD before and 4 hours after Iva; Iva sustained effect: difference between FMD before first dose of Iva (study visit 2) and after 4 weeks of Iva intake twice daily (10 to 15 mg).

Back to article page

Cardiovascular Ultrasound

ISSN: 1476-7120

Contact us